D
Lisata Therapeutics, Inc. LSTA
$2.53 $0.000.00% NASDAQ
Recommendation
Prev Close
$2.53
Volume
19,196
Avg Vol (90D)
32,373
Market Cap
$21.27M
Dividend & Yield
--
52-Week Range
$1.87 - $4.20
P/E (TTM)
--
EPS (TTM)
-$2.40
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Surprising Analyst 12-Month Target For DFAS
4/28/2025 - ETF Channel
We Think Lisata Therapeutics (NASDAQ:LSTA) Needs To Drive Business Growth Carefully
4/26/2025 - Simply Wall St
Lisata Therapeutics talks ADC breakthrough with Catalent ICYMI
4/19/2025 - Proactive Investors - UK
Lisata Therapeutics CMO discusses potential for certepetide under Catalent license agreement
4/16/2025 - Proactive Investors - UK
Market movers: Meta, HPE, Applied Digital, Lisata Therapeutics...
4/15/2025 - Proactive Investors - UK
Lisata Therapeutics (LSTA) Partners with Catalent on Preclinical Study LSTA Stock News
4/15/2025 - GuruFocus
Lisata Therapeutics announces research license with Catalent
4/15/2025 - Proactive Investors - UK
Lisata Therapeutics signs research license with Catalent
4/15/2025 - Proactive Investors - UK
Lisata Therapeutics announces research license with Catalent
4/15/2025 - Seeking Alpha - Healthcare
Lisata Therapeutics announces research license with Catalent
4/15/2025 - The Fly
Lisata Therapeutics Announces Research License with Catalent
4/15/2025 - GuruFocus
Lisata Therapeutics Announces Research License with Catalent
4/15/2025 - Globe Newswire
Analysts See 20% Upside For The Holdings of DFSU
3/25/2025 - ETF Channel
Lisata Therapeutics CEO discusses AI drug discovery collaboration - ICYMI
3/8/2025 - Proactive Investors - UK
Lisata Therapeutics expands drug discovery with GATC AI collaboration
3/7/2025 - Proactive Investors - UK
Lisata Therapeutics to Present at the Investival Showcase USA
3/6/2025 - GuruFocus
Lisata Therapeutics to Present at the Investival Showcase USA
3/6/2025 - Globe Newswire
Lisata Therapeutics partners with GATC Health to advance AI-driven drug development
3/5/2025 - Proactive Investors - UK
Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI ...
3/5/2025 - GuruFocus
Lisata Therapeutics, GATC Health consummate first step in collaboration
3/5/2025 - The Fly
Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development
3/5/2025 - Globe Newswire
Lisata Therapeutics' Earnings Call: Progress Amid Challenges
3/1/2025 - TipRanks Financial Blog
Lisata Therapeutics Inc (LSTA) Q4 2024 Earnings Call Highlights: Promising Developments Amid ...
2/28/2025 - GuruFocus
Q4 2024 Lisata Therapeutics Inc Earnings Call Transcript
2/28/2025 - GuruFocus
Lisata Therapeutics Reports 2024 Financial Results and Updates
2/28/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$1.00M
EBITDA (TTM)
-$22.24M
EBIT (TTM)
-$22.41M
Net Income (TTM)
-$19.99M
Balance Sheet
Total Assets (Q)
$35.00M
Total Debt (Q)
$137.00K
Total Liabilities (Q)
$5.69M
Book Value Per Share (Q)
$3.52
Cash Flow
Cash from Operations (TTM)
-$19.36M
Cash from Investing (TTM)
$13.23M
Cash from Financing (TTM)
-$206.00K
Net Change in Cash (TTM)
-$6.38M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.07
7-Day Total Return
21.63%
30-Day Total Return
5.86%
60-Day Total Return
-2.32%
90-Day Total Return
-1.94%
Year to Date Total Return
-29.13%
1-Year Total Return
-4.45%
2-Year Total Return
-20.57%
3-Year Total Return
-73.23%
5-Year Total Return
-92.08%
52-week Low
Apr 07, 2025 - $1.87
52-week High
Jan 06, 2025 - $4.20
Valuation
Market Cap
$21.27M - Nano Cap
Enterprise Value
-$10.09M
Price/Sales (TTM)
21.24
Price/Book (Q)
0.72
Dividends and Shares
Shares Outstanding
8.40M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.lisata.com
Phone Number
908 842 0100
Address
110 Allen Road
Basking Ridge, NJ 07920
Country
United States
Year Founded
1980
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases... more
NASDAQ 04/28/2025 3:59PM Eastern Quotes delayed